All Articles
Conditions
8 min read
March 2, 2026

Stem Cell Therapy for Multiple Sclerosis: HSCT and MSC Explained

Two types of stem cell therapy are being studied for MS: HSCT (hematopoietic stem cell transplantation) and MSC therapy. Here's what patients need to know about both.

SE

StemConnect Editorial Team

StemConnect Editorial

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Stem cell therapy is experimental for most conditions. Always consult a licensed physician before pursuing any treatment.

Stem Cell Therapy for Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the myelin sheath that protects nerve fibers. Two distinct stem cell approaches are being studied for MS, and understanding the difference is critical for patients evaluating their options.

HSCT: The More Established Approach

Hematopoietic stem cell transplantation (HSCT) is the most rigorously studied stem cell treatment for MS. It involves:

  1. Mobilization: Stem cells are stimulated to move from bone marrow into the bloodstream
  2. Harvest: Stem cells are collected and frozen
  3. Conditioning: High-dose chemotherapy destroys the existing immune system
  4. Transplant: The patient's own stem cells are reinfused to rebuild the immune system

The theory is that the new immune system will not attack myelin.

Evidence: Multiple clinical trials, including the MIST trial published in JAMA (2019), have shown that HSCT can halt MS progression and even reverse some disability in patients with aggressive relapsing-remitting MS.

Risks: HSCT carries significant risks including infection, organ damage, and in rare cases death. It is typically performed only at specialized academic medical centers.

MSC Therapy: The Emerging Approach

Mesenchymal stem cell (MSC) therapy for MS is less established than HSCT. MSCs are thought to work through immunomodulation — calming the overactive immune response — rather than resetting the immune system entirely.

Evidence: Several Phase 1/2 trials have shown safety and modest benefit, but no large Phase 3 trials have been completed.

Risks: Lower than HSCT, but still experimental.

Choosing the Right Approach

| Factor | HSCT | MSC Therapy |

|--------|------|-------------|

| Evidence level | Strong (for RRMS) | Moderate |

| Risk level | High | Moderate |

| Cost | $50,000–$150,000 (US) | $10,000–$40,000 |

| Insurance coverage | Sometimes | Rarely |

| Best for | Aggressive RRMS | Less aggressive MS |

Finding MS Stem Cell Clinics

Use the [StemConnect directory](/directory) to find clinics with MS experience. For HSCT, look for academic medical centers participating in clinical trials. For MSC therapy, look for clinics with transparent protocols and published outcomes.

This article is for informational purposes only. MS patients should work closely with a neurologist specializing in MS before pursuing any stem cell treatment.

Frequently Asked Questions

Related Conditions